MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
13
Beneficiaries
—
Total drug cost
$516
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Silver Sulfadiazine13 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$36
Payment records
1
By payment type
Food and Beverage$36
Top paying entities
Food and Beverage$36
REFERRAL NETWORK
Where Hanako Farol's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Marisa Tseng Diagnostic Radiology · Duarte, CA | 11 | 35 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| UNIVERSITY OF CALIFORNIA IRVINE | 66 | 3,951 |
| Unilab Corporation Clinical Laboratory · West Hills, CA | 11 | 70 |
| Chaitali Nangia Hematology · Costa Mesa, CA | 11 | 606 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE